Correlation Between Pfizer and BNY Mellon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and BNY Mellon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BNY Mellon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and BNY Mellon Large, you can compare the effects of market volatilities on Pfizer and BNY Mellon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BNY Mellon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BNY Mellon.

Diversification Opportunities for Pfizer and BNY Mellon

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and BNY is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BNY Mellon Large in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BNY Mellon Large and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with BNY Mellon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BNY Mellon Large has no effect on the direction of Pfizer i.e., Pfizer and BNY Mellon go up and down completely randomly.

Pair Corralation between Pfizer and BNY Mellon

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the BNY Mellon. In addition to that, Pfizer is 1.85 times more volatile than BNY Mellon Large. It trades about -0.25 of its total potential returns per unit of risk. BNY Mellon Large is currently generating about 0.18 per unit of volatility. If you would invest  11,055  in BNY Mellon Large on August 29, 2024 and sell it today you would earn a total of  391.00  from holding BNY Mellon Large or generate 3.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  BNY Mellon Large

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
BNY Mellon Large 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BNY Mellon Large are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile essential indicators, BNY Mellon may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and BNY Mellon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and BNY Mellon

The main advantage of trading using opposite Pfizer and BNY Mellon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BNY Mellon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BNY Mellon will offset losses from the drop in BNY Mellon's long position.
The idea behind Pfizer Inc and BNY Mellon Large pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals